Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR350 > CVD in Older Adults > Flashcards

CVD in Older Adults Flashcards

1
Q

What is the relationship between hypertension and age?

A

incidence increases with age
-Framingham study: lifetime risk of developing HTN is > 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which type of hypertension is most common in older adults?

A

isolated systolic hypertension
-SBP more closely correlated with CV risk in pts > 50y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the physiological changes in blood pressure seen with aging?

A

decreased baroreceptor response
impaired cerebral autoregulation
= increased risk for orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How should anti-hypertensives be started in older adults?

A

start low, go slow
-avoid overly-aggressive BP reductions due to risk of tissue hypoperfusion and ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the benefits of lowering blood pressure?

A

good evidence from multiple epidemiological studies and clinical studies that lowering high blood pressure reduces risk of:
-heart attacks
-strokes
-sudden cardiac death
-heart failure
-peripheral artery disease
-end-stage renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the evidence for hypertension and dementia risk reduction?

A

epidemiological studies have shown that elevated blood pressure in middle-age increases risk for cognitive impairment later in life
short-term clinical intervention studies of treating HTN in older adults have not shown decreased dementia risk
-often stopped early due to superiority in CV-endpoint risk reduction
-SPRINT-MIND showed decreased risk of MCI with intensive (<120) vs standard (<140) BP control over 5 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some health behavior interventions for hypertension in older adults?

A

reduce alcohol intake
DASH diet
smoking cessation
others may be somewhat less practical in older adults, particularly if frail
-caution when advising weight reduction
-sodium restriction may result in hyponatremia, orthostatic hypotension
physical activity should continue to be encouraged
-consideration for necessary safety modifications
-PT consultation?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe appropriate at home blood pressure monitoring.

A

sitting position
back supported
arm bare and supported
middle of the cuff at heart level
do not talk or move before or during the measurement
legs uncrossed
feet flat on the floor
should have rested for 5 minutes prior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which patients were excluded from SPRINT Elders?

A

diabetes
HF
history of stroke
recent MI (past 3 months)
BP < 110 mmHg after 1 min standing
dementia
LTC resident

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What were the results of SPRINT Elders?

A

SBP target < 120 mmHg (intensive) vs < 140 mmHg (standard)
-NNT 27 over 3 yrs to prevent one CV death, MI/ACS, stroke or acute decompensated HF
-NNT 43 over 3 yrs to prevent one death
-non-significant increase in syncope, hypotension, and AKI in intensive group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the thresholds and targets for blood pressure treatment according to Hypertension Canada?

A

Hypertension Canada high-risk patients:
-threshold: SBP > 120
-target: SBP < 120
diabetes mellitus:
-threshold: > 130
-target: < 130
moderate-to-high risk (TOD or CV risk factors):
-threshold: > 140
-target: < 140
low risk (no TOD or CV risk factors):
-threshold: > 160
-target: < 140

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is considered to be a Hypertension Canada high-risk patient?

A

one or more of the following:
-clinical or sub-clinical CV disease
-CKD
-FRS > 15%
-age > 75 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some considerations to keep in mind when pursuing intensive blood pressure targets in older adults?

A

orthostatic hypotension
diastolic hypotension
frailty and functional status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is orthostatic hypotension?

A

> 20 mmHg systolic and/or > 10 mmHg diastolic decrease in BP within 1-3 minutes of standing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is orthostatic hypotension a risk factor for?

A

falls
hospitalizations
CV events
functional decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is orthostatic hypotension associated with?

A

increased age
diabetes
Parkinson’s disease
dementia
medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does frailty and functional status impact intensive blood pressure control?

A

risks and treatment burden of intensive BP control may outweigh benefits in these patients
also consider time to benefit of intensive treatment (~2.5 yrs)
-is this time frame applicable to your patient?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When should we reconsider intensive BP targets in older adults?

A

functional dependency, limited life expectancy, dementia
orthostatic hypotension
diastolic hypotension + CAD
SPRINT exclusion criteria: diabetes, HF, history of stroke, recent MI
patient/family preference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a major key in determining antihypertensive choice in older adults?

A

is there a compelling indication for one or more antihypertensive?
-yes: choose agent according to compelling indication
-no: choose agent for ISH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the antihypertensives of choice for ISH?

A

thiazide
ARB
CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the antihypertensives of choice for diastolic HTN with or without systolic HTN?

A

monotherapy:
-thiazide
-BB
-ACEI/ARB
single pill combo:
-ACEI/ARB with CCB
-ACEI/ARB with thiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the antihypertensives of choice for diabetics with microalbuminuria, renal disease, or additional CV risk factors?

A

ACEI/ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the antihypertensives of choice for diabetics without any additional risk factors?

A

ACEI/ARB
DHP CCB
thiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the antihypertensives of choice for patients with CAD?

A

ACEI/ARB
BB or CCB for patients with stable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the antihypertensives of choice for patients with a recent MI?

A

BB and ACEI (ARB if ACEI intolerant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the antihypertensives of choice for patients with HF?

A

ACEI (ARB if ACEI intolerant)
BB
MRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the antihypertensives of choice for patients with LVH?

A

ACEI/ARB
CCB
thiazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the antihypertensives of choice for patients with a past stroke or TIA?

A

ACEI and thiazide combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the antihypertensives of choice for patients with non-diabetic CKD with proteinuria?

A

ACEI (ARB if ACEI intolerant)
diuretics as additive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the antihypertensives of choice for patients with PAD?

A

does not affect initial treatment recommendation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are some things to evaluate in older adults with high blood pressure despite treatment?

A

adherence?
secondary causes of hypertension
-medications (NSAIDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Which thiazide is most potent?

A

chlorthalidone 1.5-2 x more potent than HCTZ –> monitor electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the risks associated with thiazides?

A

increased gout risk
observational studies –> possible increased risk of skin cancer
electrolyte abnormalities (K and Na)
orthostatic hypotension
worsening urinary urgency/incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are some monitoring parameters for ACEI/ARB?

A

renal function
K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Can ACEI and ARBs be combined?

A

not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are some common uses of CCBs?

A

all long-acting agents can be considered for:
-uncomplicated HTN, stable angina, LVH
dihydropyridines:
-also indicated for ISH
non-dihydropyridines:
-may be useful to control HR in afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are side effects of CCBs?

A

can cause or exacerbate peripheral edema, especially higher doses
-can try split dosing or hs dosing
non-DHP:
-constipating in older adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

When should non-DHP CCBs be avoided?

A

HFrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What should non-DHP CCBs not be combined with?

A

BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What are the uses of beta-blockers?

A

not recommended as 1st line anti-hypertensive for adults > 60 yrs
still recommended in older adults if compelling indications exist:
-post-MI
-HFrEF
-control HR in afib
also may be used as add-on therapy for HTN in older adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What are the side effects of beta-blockers?

A

fatigue
decreased exercise tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is the general consensus on statin use in older adults who are secondary prevention?

A

statins should be started/continued for secondary prevention of CV events regardless of age and in mild-moderate frailty
-benefits generally outweigh risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What is the time to benefit of a statin for secondary prevention?

A

~ 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Describe the evidence for statin use in primary prevention after 75 yrs of age.

A

lack of evidence to support who should receive statin therapy for primary prevention of CV events
PREVENTABLE and STAREE clinical trials ongoing - will hopefully provide clarity
in the meantime, shared decision making:
-cardiovascular risk factors
-functional status
-medication/treatment burden
-statin associated AE
-desire to take more/less medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Which dose of statins may be preferred in older adults?

A

moderate-dose
-especially outside of the acute post-event period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are older adults more susceptible to with statins?

A

statin adverse effects
-myalgias, GI upset, fatigue, increased risk of AKI
-rare case reports of statin associated cognitive impairment (reversible on dc)

47
Q

What is the role of other cholesterol medications in older adults?

A

limited role
PCSK-9 inhibitors –> FH
fibrates may be necessary in severe hypertriglyceridemia ( > 10 mmol/L) to prevent pancreatitis
ezetimibe has limited evidence for improving CV outcomes in combinations with statins (no evidence of decreasing CV morbidity or mortality as monotherapy)
consider deprescribing if appropriate

48
Q

Are stable CAD patients considered primary or secondary prevention?

A

secondary

49
Q

What are some important considerations to keep in mind with patients with CAD?

A

time since event
symptom stability
activity level
patient goals and preferences

50
Q

What is the medication cocktail after ACS?

A

beta-blocker, ACEI/ARB, statin, ASA
others as needed:
-other antihypertensives for BP
-other anti-anginals as needed: CCB, long-acting or prn nitroglycerin

51
Q

What lifestyle change might decrease the medication requirements for patients who have had ACS?

A

as activity level decreases, medication requirements might decrease also

52
Q

Describe antiplatelet use after ACS.

A

ASA indefinitely
-clopidogrel if contraindicated
-consider adding PPI if history of GI bleed

53
Q

Describe BB use after ACS.

A

evidence of decreased CV risk up to 3 years post-MI
-titrate to resting HR of ~ 60 bpm

54
Q

When should BB use be reconsidered after ACS?

A

after 3 years re-evaluate based on symptoms and comorbidities
-indicated indefinitely for HFrEF
-reasonable to continue if angina symptoms, afib needing rate control
-if poorly tolerated –> re-evaluate if > 3 y post-MI

55
Q

Describe ACEI/ARB use in stable CAD.

A

recommended for all individuals with stable CAD and HTN, DM, HFrEF, or CKD
continue indefinitely as tolerated

56
Q

Describe CCB use in stable CAD.

A

angina if beta-blockers CI or not tolerated
diltiazem or verapamil may also be used for rate control in afib

57
Q

When are short-acting nitrates used in CAD?

A

rescue or prophylactically prior to activities which provoke symptoms
-ensure using properly

58
Q

What are some side effects of nitrates?

A

dizziness
headache
hypotension
flushing
edema

59
Q

When are long-acting nitrates used in CAD?

A

may be added when BB and/or CCB are CI, not tolerated, or not providing adequate symptom relief

60
Q

What needs to be ensured is done with long-acting nitrates?

A

12h nitrate-free period

61
Q

Which class of drugs contributes to the most ED visits for ADRs?

A

anticoagulants and antiplatelets

62
Q

What is atrial fibrillation?

A

abnormal electrical conduction in the atria –> chaotic, uncoordinated contraction

63
Q

What are the symptoms of atrial fibrillation?

A

may be asymptomatic or may experience:
-SOB, fatigue
-palpitations
-chest discomfort
-anxiety, sweating

64
Q

What are the two key clinical issues with atrial fibrillation?

A

significant increased risk of ischemic stroke
increased heart rate –> heart failure

65
Q

How is stroke risk managed in atrial fibrillation?

A

anticoagulation
-warfarin or DOAC

66
Q

What is the dilemma with age and atrial fibrillation?

A

incidence of atrial fibrillation increases with age
advanced age increases the risk for both major bleeds & stroke

67
Q

What often becomes a deterrent to anticoagulation from a physician perspective?

A

advanced age
-underestimation of benefit

68
Q

What are the advantages of DOACs over warfarin?

A

> efficacy
less ICH
no INR monitoring
fewer drug and food interactions

69
Q

What are the disadvantages of DOACs compared to warfarin?

A

cost, EDS
more GI bleeds (rivaroxaban, edoxaban, dabigatran)
less long-term safety data
caution in renal impairment

70
Q

What are contraindications of DOACs?

A

severe renal impairment
not indicated with mechanical heart valves

71
Q

When do we consider changing from warfarin to DOAC?

A

really anyone that doesnt have an indication for warfarin
-ex: significant DDI, cant get to lab, labile INRs

72
Q

When is warfarin preferrable to a DOAC?

A

severe renal dysfunction
mechanical heart valve

73
Q

Describe key factors to consider with each DOAC when determining which one to choose.

A

dabigatran:
-most GI upset
-most highly renally eliminated
-BEERS if 75 and older
rivaroxaban:
-once daily dosing with food
-BEERS if 75 and older
edoxaban:
-once daily dosing
-watch for DDI (decrease dose with P-gp inhibitors)
apixaban:
-best safety data (so far)
-best choice when renal function is borderline

74
Q

What are some considerations to be keeping in mind for anticoagulation in atrial fibrillation?

A

is there an indication? (always in older adults due to age > 65)
is there a high risk of bleeding or a CI?
will the patient be able to adhere to therapy or monitoring?
patient/family preferences?

75
Q

Which HAS-BLED score starts to require caution?

A

3 or greater

76
Q

Does fall risk preclude anticoagulation for afib stroke prevention?

A

no

77
Q

What are some important considerations to keep in mind with anticoagulants and the ability of older patients to adhere to the monitoring requirements?

A

warfarin:
-INR monitoring
-ability to self-manage dosage adjustments?
DOACs:
-consistent adherence is very important
-also need to check CBC, renal function q 6 months

78
Q

What are some factors to consider when deciding between rate vs rhythm control?

A

duration of afib
bothersome afib symptoms?
comorbid HF?

79
Q

Which antiarrhythmics are preferred for rhythm control if the patient has heart failure?

A

LVEF < 40%: amiodarone
LVEF > 40%: amiodarone, sotalol

80
Q

Which antiarrhythmics are preferred for rhythm control if the patient has CAD?

A

amiodarone
dronedarone
sotalol

81
Q

Which antiarrhythmics are preferred for rhythm control if the patient has no HF nor CAD?

A

amiodarone
dronedarone
flecainide
propafenone
sotalol

82
Q

What occurs to the likelihood of successful rhythm control as afib duration increases?

A

likelihood of successful rhythm control decreases as afib duration increases
-perhaps why previous trials did not show benefit with rhythm control

83
Q

What is an important monitoring parameter for antiarrhythmics in older adults?

A

adverse effects

84
Q

What are the adverse effects of amiodarone?

A

optic neuropathy and neuritis
pulmonary and hepatic toxicity
hypo or hyperthyroidism
blue-grey skin discolouration
photosensitivity

85
Q

What are some of the many drug interactions of amiodarone?

A

warfarin
digoxin
beta-blockers/non-DHP CCB

86
Q

Which medications are used for rate control?

A

beta-blockers
non-DHP CCB
2nd line: digoxin (additive), amiodarone

87
Q

When are beta-blockers preferred for rate control?

A

when concurrent CAD, HF

88
Q

When are non-DHP CCB preferred for rate control?

A

severe or poorly controlled asthma/COPD

89
Q

When is digoxin used for rate control?

A

usually used as add-on therapy
may be beneficial if concurrent symptomatic HF

90
Q

Why is digoxin not preferred for rate control?

A

less effective - does not control HR during exercise
AFFIRM trial - increased mortality when digoxin used for afib

91
Q

What is the HR target in afib?

A

< 100 bpm at rest

92
Q

Describe digoxin monitoring in afib.

A

monitoring for efficacy: target HR
-serum digoxin levels are not a target to aim for but a tool to avoid toxicity
monitoring for toxicity:
-serum levels if concerned about AE/DI/renal function
-digoxin AE: NVD, decreased appetite, dizziness, confusion/delirium, “halos”
-older adults much more susceptible to digoxin toxicity
-ideally maintain trough level < 1 nmol/L

93
Q

Is rate or rhythm control preferred in older adults?

A

rate control used to be preferred management option
-new evidence suggests benefit for rhythm control in early afib –> may start seeing this more frequently

94
Q

Differentiate HFrEF and HFpEF.

A

HFrEF:
-LVEF < 40%
-less blood pumped out of ventricles, weakened heart muscle cant squeeze as well
HFpEF:
-LVEF > 50%
-less blood fills the ventricles, stiff heart muscle cant relax normally

95
Q

What is the standard therapy for HFrEF?

A

ACEI/ARB/ARNI
BB
MRA
SGLT2

96
Q

Which drug should be started first in HFrEF?

A

currently no consensus regarding which drug classes to start with when initiating treatment for HFrEF
-start with one drug class and titrate up to max tolerated dose?
-start with more than one drug class at smaller dose?
decisions should be based on clinical characteristics of the patient
-hemodynamic status
-renal function
-side effects/tolerability
-cost
-adherence

97
Q

What did PARADIGM-HF show?

A

Entresto vs enalapril
-decrease CV mortality and HF hospitalization

98
Q

What is required when switching from ACEI to ARNI?

A

36 hour washout

99
Q

What are some monitoring parameters for ACEI/ARB/ARNI?

A

SCr, lytes within 1-2 weeks of initiation/titration
sitting and standing BP
-orthostatic hypotension may warrant dose decrease
-use lowest required dose of diuretic

100
Q

What are frail older adults more susceptible to with ARNI compared to ACEI/ARB alone?

A

hypotension/orthostatic hypotension

101
Q

Which beta blockers are used in HFrEF?

A

bisoprolol
metoprolol
carvedilol

102
Q

Which MRAs are used in HFrEF?

A

spironolactone
eplerenone

103
Q

What is a BEERS criteria for MRAs?

A

avoid if CrCl < 30 ml/min

104
Q

What did DAPA-HF and EMPEROR REDUCED show?

A

benefit of dapa and empa in decreasing HF hospitalizations or CV death
-~50% of patients had T2DM
-no significant difference in AE

105
Q

What are monitoring parameters for SGLT2i?

A

decrease in eGFR ~15% on initiation
volume status - may need to decrease diuretic dose on initiation in euvolemic patients

106
Q

What are some precautions for SGLT2i?

A

decrease BP ~1-2 mmHg
“sick day” management

107
Q

How do older adults tolerate SGLT2i?

A

increase risk of genital fungal infections
? increase in UTI
? increase in DKA
use with caution in older adults - BEERS 2023

108
Q

What is the use of loop diuretics in HF?

A

symptomatic treatment
-SOB, fluid retention, increased weight
use lowest effective dose

109
Q

What is the use of digoxin in HF?

A

add-on if symptoms despite optimized 1st and 2nd line meds
-may also help decrease resting HR in afib

110
Q

What is Torsades de Pointes?

A

arrhythmia that may lead to sudden cardiac death
-associated with prolonged QT interval and bradycardia
-may be congenital or acquired

111
Q

What are the risk factors for acquired TdP?

A

older age
female
elyte disturbances: hypokalemia/calcemia/magnesemia
drugs
renal or liver disease
hypertension
smoking
arrhythmia, prior MI, cardiomyopathy

112
Q

What are some common medications that prolong the QT interval?

A

antiarrhythmics
-sotalol, amiodarone, propafenone, flecainide, etc
ADHD
-atomoxetine
antiemetics
-domperidone
antipsychotics
-aripip, haloperidol, pimozide, quet > risp, cloz
SSRIs
-sertraline, citalopram, escitalopram > others
SNRIs
-mirtazapine > venlafaxine
TCAs
-all > nortriptyline
antibiotics
-moxifloxacin > levofloxacin or ciprofloxacin
-clarithromycin, erythromycin > azithromycin
antifungals
-fluconazole > others
miscellaneous
-donepezil, hydroxyzine, methadone, tramadol

113
Q

What is the RISQ-PATH score that predicts a high risk of QT prolongation?

A

10 or greater

PHAR350 (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions